Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Wiley 2019-01-01
Cyfres:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Pynciau:
atrial fibrillation
biomarker
left ventricular hypertrophy
risk prediction
Mynediad Ar-lein:https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

Rhyngrwyd

https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

Eitemau Tebyg